Nasal allergen‐neutralizing antibodies correlate closely with tolerated intranasal allergen challenge dose following grass pollen subcutaneous immunotherapy in patients with local allergic rhinitis
Fuente:
Wiley Open Access
Enregistré dans:
| Auteurs principaux: | Ibon Eguiluz‐Gracia, Rebecca V. Parkin, Janice A. Layhadi, Elizabeth Palmer, Xun Meng, Rongfei Zhu, Umit Sahiner, Stephen R. Durham, Maria Jose Torres, Cristobalina Mayorga, Carmen Rondon, Mohamed H. Shamji |
|---|---|
| Format: | Artículo Open Access |
| Publié: |
Wiley
2024
|
| Sujets: | |
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
Early expansion of allergen‐responsive LAP+ B regulatory cells in allergic rhinitis but not in allergic asthma subjects during allergen immunotherapy
par: Astrid L. Voskamp, et autres
Publié: (2024)
par: Astrid L. Voskamp, et autres
Publié: (2024)
Treatment of allergic rhinitis with allergen immunotherapy in children and adolescents—Adherence, rhinitis severity, and asthma onset
par: Anna M. Hedman, et autres
Publié: (2026)
par: Anna M. Hedman, et autres
Publié: (2026)
Peripheral blood mononuclear cell transcriptome profile in a clinical trial with subcutaneous, grass pollen allergoid immunotherapy
par: Sviatlana Starchenka, et autres
Publié: (2024)
par: Sviatlana Starchenka, et autres
Publié: (2024)
Reply to correspondence: “The effectiveness of pollen allergen immunotherapy on allergic rhinitis over 18 years: A national cohort study in Denmark”
par: Peter Bager, et autres
Publié: (2024)
par: Peter Bager, et autres
Publié: (2024)
Investigation of the diagnostic accuracy of basophil activation test for allergic phenotypes of rhinitis
par: Almudena Testera‐Montes, et autres
Publié: (2024)
par: Almudena Testera‐Montes, et autres
Publié: (2024)
Editorial comment on “Efficacy and safety of sublingual immunotherapy using house dust mite tablet for 1–4 years old children with perennial allergic rhinitis”
par: Umit Murat Sahiner, et autres
Publié: (2024)
par: Umit Murat Sahiner, et autres
Publié: (2024)
Preventive allergen immunotherapy with inhalant allergens in children
par: Varsha Dwivedi, et autres
Publié: (2024)
par: Varsha Dwivedi, et autres
Publié: (2024)
Cost‐effectiveness of subcutaneous immunotherapy for house dust mite‐induced allergic rhinitis in China
par: Lei Ren, et autres
Publié: (2025)
par: Lei Ren, et autres
Publié: (2025)
Mite allergen sensitization patterns in Turkish children: Age‐related changes and molecular correlations
par: Sevda Tuten Dal, et autres
Publié: (2024)
par: Sevda Tuten Dal, et autres
Publié: (2024)
Immune signatures predict response to house dust mite subcutaneous immunotherapy in patients with allergic rhinitis
par: Nan Wang, et autres
Publié: (2024)
par: Nan Wang, et autres
Publié: (2024)
Systemic reactions to house dust mite subcutaneous immunotherapy in patients with allergic rhinitis and/or asthma: A real‐life, multi‐center study
par: Qingxiu Xu, et autres
Publié: (2024)
par: Qingxiu Xu, et autres
Publié: (2024)
Clinical validation of grass pollen exposure chamber in patients with allergic rhinitis triggered by timothy grass
par: Anna Kosowska, et autres
Publié: (2024)
par: Anna Kosowska, et autres
Publié: (2024)
Digitally‐enabled, person‐centred care (PCC) in allergen immunotherapy: An ARIA‐EAACI Position Paper
par: Oliver Pfaar, et autres
Publié: (2024)
par: Oliver Pfaar, et autres
Publié: (2024)
Efficacy and safety of intranasal medications for allergic rhinitis: Network meta‐analysis
par: Bernardo Sousa‐Pinto, et autres
Publié: (2024)
par: Bernardo Sousa‐Pinto, et autres
Publié: (2024)
Binding of food allergens to nanoplastics and their effect on allergic responses
par: Apostolovic, Danijela, et autres
Publié: (2025)
par: Apostolovic, Danijela, et autres
Publié: (2025)
The first plant allergen to be cloned—the story of the major birch pollen allergen Bet v 1
par: Heimo Breiteneder
Publié: (2024)
par: Heimo Breiteneder
Publié: (2024)
A recent patent in allergy & immunology: Biomarkers on allergen‐specific memory B cells to predict allergen immunotherapy outcome
par: Menno C. van Zelm, et autres
Publié: (2024)
par: Menno C. van Zelm, et autres
Publié: (2024)
What is the role of oral or subcutaneous immunotherapy in the management of bronchial asthma and allergic rhinitis, and how does it compare to inhaled steroid therapy?
par: Tripdatabase
Publié: (2025)
par: Tripdatabase
Publié: (2025)
Identification of fructose‐bisphosphate aldolase as new pollen allergens
par: Le‐Bin Song, et autres
Publié: (2024)
par: Le‐Bin Song, et autres
Publié: (2024)
The polysaccharide Pullulan improves the initial steps of allergen‐specific immunotherapy in dogs
par: Franco Martini, et autres
Publié: (2026)
par: Franco Martini, et autres
Publié: (2026)
Differential modulation of allergic rhinitis nasal transcriptome by dupilumab and allergy immunotherapy
par: Matthew F. Wipperman, et autres
Publié: (2024)
par: Matthew F. Wipperman, et autres
Publié: (2024)
Effect and mechanism of allergen‐specific immunotherapy on small airway dysfunction in children with asthma
par: Wenwei Zhong, et autres
Publié: (2024)
par: Wenwei Zhong, et autres
Publié: (2024)
The effect of allergen immunotherapy in patients with central compartment atopic disease post‐surgery
par: Christian M. Meerwein, et autres
Publié: (2024)
par: Christian M. Meerwein, et autres
Publié: (2024)
Non-allergenic mixed T cell epitope peptides for preventing Scy p 9 allergic reactions.
par: He, Xinrong, et autres
Publié: (2025)
par: He, Xinrong, et autres
Publié: (2025)
Expansion of phenotypically modified type 2 memory B cells after allergen immunotherapy
par: Anouk von Borstel, et autres
Publié: (2024)
par: Anouk von Borstel, et autres
Publié: (2024)
Model‐informed exploration of the boundaries of safe aluminium exposure from allergen immunotherapy in children
par: Karin Weisser, et autres
Publié: (2025)
par: Karin Weisser, et autres
Publié: (2025)
IL ‐10‐modulated dendritic cells from birch pollen‐ and hazelnut‐allergic patients facilitate Treg‐mediated allergen‐specific and cross‐reactive tolerance
par: Patricia Vanessa Heinl, et autres
Publié: (2024)
par: Patricia Vanessa Heinl, et autres
Publié: (2024)
Skin, gut, and lung barrier: Physiological interface and target of intervention for preventing and treating allergic diseases
par: Roberto Berni Canani, et autres
Publié: (2024)
par: Roberto Berni Canani, et autres
Publié: (2024)
Evaluation of clinical outcomes of efficacy in food allergen immunotherapy trials, COFAITH EAACI task force
par: Pablo Rodríguez del Río, et autres
Publié: (2024)
par: Pablo Rodríguez del Río, et autres
Publié: (2024)
Intradermal immunotherapy with low-dose house dust mite allergens: A proof-of-concept study
par: Alberto Vieira-Hernández
Publié: (2018)
par: Alberto Vieira-Hernández
Publié: (2018)
SQ sublingual immunotherapy tablets for children with allergic rhinitis: A review of phase three trials
par: Péter Csonka, et autres
Publié: (2024)
par: Péter Csonka, et autres
Publié: (2024)
Causative allergens of eyelid dermatitis in Greece
par: Dimitra Koumaki, et autres
Publié: (2024)
par: Dimitra Koumaki, et autres
Publié: (2024)
Food and inhaled allergens may play a more prominent role in allergic transfusion reactions than previously recognized
par: Kazuta Yasui, et autres
Publié: (2024)
par: Kazuta Yasui, et autres
Publié: (2024)
Sensitization profiles to house dust mite Dermatophagoides pteronyssinus molecular allergens in the Lithuanian population: Understanding allergic sensitization patterns
par: Gabija Biliute, et autres
Publié: (2024)
par: Gabija Biliute, et autres
Publié: (2024)
Roles of noncoding RNA in allergic rhinitis
par: Xiangkun Zhao, et autres
Publié: (2024)
par: Xiangkun Zhao, et autres
Publié: (2024)
Assessing allergenic potential, exposure and risk of spp.
par: Majstorović, J, et autres
Publié: (2025)
par: Majstorović, J, et autres
Publié: (2025)
Research progress and immunological insights of shrimp allergens.
par: Xu, Bao-Liang, et autres
Publié: (2025)
par: Xu, Bao-Liang, et autres
Publié: (2025)
Styrene epoxide: Unusual allergen in clinical practice
par: Daniela Calderón, et autres
Publié: (2024)
par: Daniela Calderón, et autres
Publié: (2024)
Induction of tolerance to food allergens—Younger is better
par: Johanna M. Smeekens, et autres
Publié: (2025)
par: Johanna M. Smeekens, et autres
Publié: (2025)
Azelastine‐fluticasone intranasal therapy: A paradigm shift in pediatric allergic rhinitis management. A point of view of the Italian Society of Pediatric Allergy and Immunology
par: Gianluigi Marseglia, et autres
Publié: (2026)
par: Gianluigi Marseglia, et autres
Publié: (2026)
Documents similaires
-
Early expansion of allergen‐responsive LAP+ B regulatory cells in allergic rhinitis but not in allergic asthma subjects during allergen immunotherapy
par: Astrid L. Voskamp, et autres
Publié: (2024) -
Treatment of allergic rhinitis with allergen immunotherapy in children and adolescents—Adherence, rhinitis severity, and asthma onset
par: Anna M. Hedman, et autres
Publié: (2026) -
Peripheral blood mononuclear cell transcriptome profile in a clinical trial with subcutaneous, grass pollen allergoid immunotherapy
par: Sviatlana Starchenka, et autres
Publié: (2024) -
Reply to correspondence: “The effectiveness of pollen allergen immunotherapy on allergic rhinitis over 18 years: A national cohort study in Denmark”
par: Peter Bager, et autres
Publié: (2024) -
Investigation of the diagnostic accuracy of basophil activation test for allergic phenotypes of rhinitis
par: Almudena Testera‐Montes, et autres
Publié: (2024)